国家肺癌筛查试验中肺癌切除术后长期生存
本研究基于国家肺癌筛查试验(NLST),评估病理IA期非小细胞肺癌(NSCLC)术后长期生存及死因。共380例患者,肺叶切除329例(86.6%)、肺段切除20例(5.3%)、楔形切除31例(8.1%)。肺叶切除10年总生存率58.3%,肺癌为肺叶切除后首位死因(占55.8%)。
要点
- NLST中病理IA期NSCLC术后10年总生存率肺叶切除58.3%、肺段切除59.9%、楔形切除45.2%。
- 10年肺癌特异性生存率肺叶切除74.3%、肺段切除81.3%、楔形切除84.8%。
- 肺叶切除后肺癌为首位死因,占55.8%,10年肺癌死亡累积发生率22.5%。
核心结论
- NLST中病理IA期NSCLC肺叶切除术后10年总生存率为58%。
- 肺癌是肺叶切除后首位死因,占死亡超过55%。
研究设计与样本
- 研究纳入NLST中接受手术且病理诊断为IA期NSCLC的患者进行分析。
- 共380例患者,其中肺叶切除329例(86.6%)、肺段切除20例(5.3%)、楔形切除31例(8.1%)。
- 评估按手术方式分层的5年和10年总生存率及肺癌特异性生存率;肺叶切除患者分析死因和肺癌死亡累积发生率。
- 手术日期起中位随访时间7.8年(四分位距4.8-10.7年)。
主要发现
- 10年总生存率:肺叶切除58.3%(95%CI 52.4%-63.8%),肺段切除59.9%(95%CI 33.2%-78.8%),楔形切除45.2%(95%CI 20.8%-66.9%)。
- 10年肺癌特异性生存率:肺叶切除74.3%(95%CI 68.6%-79.1%),肺段切除81.3%(95%CI 51.3%-93.8%),楔形切除84.8%(95%CI 64.0%-94.1%)。
- 肺癌是肺叶切除后首位死因,占55.8%。
- 肺叶切除后10年肺癌死亡累积发生率为22.5%(95%CI 18.3%-27.1%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study sought to evaluate the long-term survival and causes of death after surgery among patients with pathologic stage IA non-small cell lung cancer (NSCLC) in the National Lung Screening Trial (NLST). METHODS: Patients who underwent surgery and who had a diagnosis of pathologic stage IA NSCLC in the NLST were identified for analysis. The 5- and 10-year overall survival and lung cancer-specific survival, stratified by operation type, were evaluated. Among patients who underwent lobectomy, the causes of death and the cumulative incidence of lung cancer death were assessed. RESULTS: A total of 380 patients (n = 329, 86.6% lobectomy; n = 20, 5.3% segmentectomy; n = 31, 8.1% wedge resection) met inclusion criteria. Median follow-up time from the date of surgery was 7.8 years (interquartile range, 4.8-10.7 years). The 10-year overall survival rate was 58.3% (95% CI, 52.4%-63.8%) for lobectomy, 59.9% (95% CI, 33.2%-78.8%) for segmentectomy, and 45.2% (95% CI, 20.8%-66.9%) for wedge resection. The 10-year lung cancer-specific survival rate was 74.3% (95% CI, 68.6%-79.1%) for lobectomy, 81.3% (95% CI, 51.3%-93.8%) for segmentectomy, and 84.8% (95% CI, 64.0%-94.1%) for wedge resection. Lung cancer was the leading cause of death, accounting for 55.8% of deaths after lobectomy. The 10-year cumulative incidence of lung cancer death after lobectomy was 22.5% (95% CI, 18.3%-27.1%). CONCLUSIONS: The 10-year overall survival rate after lobectomy among patients with pathologic stage IA NSCLC in the NLST was 58%. Lung cancer was the leading cause of death, accounting for more than 55% of deaths.
引用
- Potter AL, Senthil P, Keshwani A, et al. Long-term Survival After Lung Cancer Resection in the National Lung Screening Trial. Ann Thorac Surg. 2024. PMID: 38216080. doi:10.1016/j.athoracsur.2023.12.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。